Industry Research Reports and Market Analysis at MindBranch.com

Spain Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Published By: Global Markets Direct
May 2009
R3480-13927
Online Download   $2,500.00
Global Site License   $7,500.00
Description

Spain Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Spain cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in Spain

Scope
  • The report provides cardiovascular devices market information broken down into detailed categories and segments in Spain.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the cardiovascular devices market in Spain.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Pacemakers
3.2.1.1 Single Chamber Pacemakers
3.2.1.2 Dual Chamber Pacemakers
3.2.2 Implantable Cardioverter Defibrillator (ICD)
3.2.2.1 Single Chamber Implantable Cardioverter Defibrillator
3.2.2.2 Dual Chamber Implantable Cardioverter Defibrillator
3.2.3 Cardiovascular Pacing and ICD Leads
3.2.4 Cardiac Resynchronization Therapy
3.2.4.1 Cardiac Resynchronisation Therapy - Pacemaker
3.2.4.2 Cardiac Resynchronisation Therapy - Defibrillator
3.3 Cardiovascular monitoring and diagnostic devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Holter Monitoring Systems
3.3.4 Event Monitoring Systems
3.4 Cardiovascular prosthetic device
3.4.1 Prosthetic heart valves
3.4.1.1 Mechanical heart valves
3.4.1.2 Tissue heart valve
3.4.2 Cardiac Valve Repair
3.4.3 Cardiac assist devices (Ventricular Assist Device (VAD))
3.4.3.1 Total Artificial Heart (TAH)
3.4.3.2 Intra Aortic Balloon Pump (IABP)
3.4.3.3 Intra Aortic Balloon Pump Catheters
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Systems
3.5.2 Perfusion Systems
3.5.3 Cardiac Ablation Devices
3.5.4 Cardiopulmonary Bypass Equipment
3.5.5 Perfusion Disposables
3.5.5.1 Oxygenators
3.5.5.2 Custom Packs
3.6 Electrophysiology
3.6.1 Electrophysiology diagnostic catheter
3.6.2 Electrophysiology ablation catheter
3.6.3 Electrophysiology lab systems
3.7 Interventional cardiology
3.7.1 Coronary Stents
3.7.1.1 Bare Metal Stents
3.7.1.2 Drug Eluting Coronary Stents
3.7.2 Cardiac Catheters
3.7.2.1 Guiding Catheters
3.7.2.2 Angiography catheters
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
3.7.3.1 Rapid Exchange PTCA Balloon Catheters
3.7.3.2 Over the Wire PTCA Balloon Catheters
3.7.3.3 Fixed Wire (FW) PTCA Balloon Catheters
3.7.4 Coronary Guidewire
3.7.5 Arteriotomy Closure Devices
3.8 Peripheral vascular devices
3.8.1 Peripheral Vascular Stents
3.8.2 Inferior Vena Cava Filter
3.8.3 PTA Balloon
3.8.4 Aortic Stent Graft
3.8.5 Embolic Protection Device
3.8.6 Synthetic Surgical Grafts
3.8.7 Peripheral Guidewire
4 Healthcare Sector Review
4.1 Healthcare Sector Review
4.2 Healthcare Expenditure
4.3 Healthcare Infrastructure
4.4 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of Medical Devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Classificazione Nazionale Dispositivi (CND) - New Medical Device Classification
5.3 Post Market Surveillance
6 Pricing and Reimbursement
6.1 Market Pricing
6.2 Government Policies for Reimbursement
7 Distribution Structure
8 Cardiovascular Devices In Italy
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, Italy, Overall Revenue ($ mn), 2000-2015
8.3 Cardiovascular Devices, Italy, Category Volume (Units), 2000-2015
8.4 Cardiovascular Devices, Italy, Company Share (2007-2008)
9 Cardiac Rhythm Management In Italy
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
9.1.3 Pacemaker Overall Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015)
9.2.3 Pacemaker Overall Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, Italy, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices In Italy
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, Italy, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices In Italy
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices Overall Volume (2000-2015)
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, Italy, Company Share (2007-2008)
12 Cardiovascular Surgery In Italy
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Overall Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Overall Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, Italy, Company Share (2007-2008)
13 Electrophysiology In Italy
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Distribution Share (2007-2008)
13.5 Electrophysiology, Italy, Company Share (2007-2008)
14 Interventional Cardiology In Italy
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Overall Revenue (2000-2015)
14.1.2 Coronary Stent Overall Revenue (2000-2015)
14.1.3 PTCA Balloon Overall Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Overall Volume (2000-2015)
14.2.2 Coronary Stent Overall Volume (2000-2015)
14.2.3 PTCA Balloon Overall Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, Italy, Company Share (2007-2008)
15 Peripheral Vascular Devices In Italy
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, Italy, Company Share (2007-2008)
16 Overview of Key Companies in Italy Cardiovascular Devices Market
16.1 Boston Scientific Corporation
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.2.1 Manufacturing
16.1.2.2 Product Development
16.1.2.3 Sales and Marketing
16.1.3 Boston Scientific Corporation Pipeline Products
16.1.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type
16.1.3.2 Boston Scientific Corporation Pipeline Products by Development Stage
16.1.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area
16.1.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials
16.1.3.5 Boston Scientific Corporation Pipeline Products by News Summary
16.2 Medtronic, Inc.
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.2.1 Manufacturing
16.2.2.2 Product Development
16.2.2.3 Sales and Marketing
16.2.3 Medtronic, Inc. Pipeline Products
16.2.3.1 Medtronic, Inc. Pipeline Products by Equipment Type
16.2.3.2 Medtronic, Inc. Pipeline Products by Development Stage
16.2.3.3 Medtronic, Inc. Pipeline Products by Therapy Area
16.2.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials
16.2.3.5 Medtronic, Inc. Pipeline Products by News Summary
16.3 Cordis Corporation
16.3.1 Company Overview
16.3.2 Cordis Corporation Pipeline Products
16.3.2.1 Cordis Corporation Pipeline Products by Equipment Type
16.3.2.2 Cordis Corporation Pipeline Products by Development Stage
16.3.2.3 Cordis Corporation Pipeline Products by Therapy Area
16.3.2.4 Cordis Corporation Pipeline Products by Clinical Trials
16.3.2.5 Cordis Corporation Pipeline Products by News Summary
16.4 Abbott Laboratories
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.2.1 Manufacturing
16.4.2.2 Product Development
16.4.2.3 Sales and Marketing
16.5 St. Jude Medical Inc.
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.2.1 Manufacturing
16.5.2.2 Product Development
16.5.2.3 Sales and Marketing
16.5.3 St. Jude Medical Inc. Pipeline Products
16.5.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type
16.5.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage
16.5.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area
16.5.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials
16.5.3.5 St. Jude Medical Inc. Pipeline Products by News Summary
16.6 BIOTRONIK GmbH & Co. KG
16.6.1 Company Overview
16.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
16.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage
16.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area
16.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials
16.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary
16.7 Sorin S.p.A.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.2.1 Manufacturing
16.7.2.2 Product Development
16.7.2.3 Sales and Marketing
16.7.3 Sorin Group Pipeline Products
16.7.3.1 Sorin Group Pipeline Products by Equipment Type
16.7.3.2 Sorin Group Pipeline Products by Development Stage
16.7.3.3 Sorin Group Pipeline Products by Therapy Area
16.7.3.4 Sorin Group Pipeline Products by Clinical Trials
16.7.3.5 Sorin Group Pipeline Products by News Summary
16.8 GE Healthcare
16.8.1 Company Overview
16.9 Philips Healthcare
16.9.1 Company Overview
16.9.2 Value Chain Analysis
16.9.2.1 Manufacturing
16.9.2.2 Product Development
16.9.2.3 Sales and Marketing
16.9.3 Philips Medical Systems Pipeline Products
16.9.3.1 Philips Medical Systems Pipeline Products by Equipment Type
16.9.3.2 Philips Medical Systems Pipeline Products by Development Stage
16.9.3.3 Philips Medical Systems Pipeline Products by Therapy Area
16.9.3.4 Philips Medical Systems Pipeline Products by Clinical Trials
16.9.3.5 Philips Medical Systems Pipeline Products by News Summary
16.10 OSI Systems, Inc.
16.10.1 Company Overview
16.10.2 Value Chain Analysis
16.10.2.1 Manufacturing
16.10.2.2 Product Development
16.10.2.3 Sales and Marketing
16.11 Cardiac Science Corporation
16.11.1 Company Overview
16.11.2 Value Chain Analysis
16.11.2.1 Manufacturing
16.11.2.2 Product Development
16.11.2.3 Sales and Marketing
16.12 Nihon Kohden Corporation
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.2.1 Manufacturing
16.12.2.2 Product Development
16.12.2.3 Sales and Marketing
16.13 Welch Allyn Inc.
16.13.1 Company Overview
16.14 Card Guard AG
16.14.1 Company Overview
16.15 Edwards Lifesciences Corporation
16.15.1 Company Overview
16.15.2 Value Chain Analysis
16.15.2.1 Manufacturing
16.15.2.2 Product Development
16.15.2.3 Sales and Marketing
16.15.3 Edwards Lifesciences Corporation Pipeline Products
16.15.3.1 Edwards Lifesciences Corporation Pipeline Products by Equipment Type
16.15.3.2 Edwards Lifesciences Corporation Pipeline Products by Development Stage
16.15.3.3 Edwards Lifesciences Corporation Pipeline Products by Therapy Area
16.15.3.4 Edwards Lifesciences Corporation Pipeline Products by Clinical Trials
16.15.3.5 Edwards Lifesciences Corporation Pipeline Products by News Summary
16.16 Thoratec Corporation
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.16.2.1 Manufacturing
16.16.2.2 Product Development
16.16.2.3 Sales and Marketing
16.16.3 Thoratec Corporation Pipeline Products
16.16.3.1 Thoratec Corporation Pipeline Products by Equipment Type
16.16.3.2 Thoratec Corporation Pipeline Products by Development Stage
16.16.3.3 Thoratec Corporation Pipeline Products by Therapy Area
16.16.3.4 Thoratec Corporation Pipeline Products by Clinical Trials
16.16.3.5 Thoratec Corporation Pipeline Products by News Summary
16.17 Datascope Corporation
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.2.1 Manufacturing
16.17.2.2 Product Development
16.17.2.3 Sales and Marketing
16.18 Arrow International, Inc.
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.2.1 Manufacturing
16.18.2.2 Product Development
16.18.2.3 Sales and Marketing
16.18.3 Arrow International, Inc. Pipeline Products
16.18.3.1 Arrow International, Inc. Pipeline Products by Equipment Type
16.18.3.2 Arrow International, Inc. Pipeline Products by Development Stage
16.18.3.3 Arrow International, Inc. Pipeline Products by Therapy Area
16.18.3.4 Arrow International, Inc. Pipeline Products by Clinical Trials
16.19 ABIOMED, Inc.
16.19.1 Company Overview
16.19.2 Value Chain Analysis
16.19.2.1 Manufacturing
16.19.2.2 Product Development
16.19.2.3 Sales and Marketing
16.19.3 ABIOMED, Inc. Pipeline Products
16.19.3.1 ABIOMED, Inc. Pipeline Products by Equipment Type
16.19.3.2 ABIOMED, Inc. Pipeline Products by Development Stage
16.19.3.3 ABIOMED, Inc. Pipeline Products by Therapy Area
16.19.3.4 ABIOMED, Inc. Pipeline Products by Clinical Trials
16.19.3.5 ABIOMED, Inc. Pipeline Products by News Summary
16.20 MAQUET GmbH & Co. KG
16.20.1 Company Overview
16.21 AtriCure, Inc.
16.21.1 Company Overview
16.21.2 AtriCure, Inc. Pipeline Products
16.21.2.1 AtriCure, Inc. Pipeline Products by Equipment Type
16.21.2.2 AtriCure, Inc. Pipeline Products by Development Stage
16.21.2.3 AtriCure, Inc. Pipeline Products by Therapy Area
16.21.2.4 AtriCure, Inc. Pipeline Products by Clinical Trials
16.21.2.5 AtriCure, Inc. Pipeline Products by News Summary
16.22 Terumo Corporation
16.22.1 Company Overview
16.22.2 Value Chain Analysis
16.22.2.1 Manufacturing
16.22.2.2 Product Development
16.22.2.3 Sales and Marketing
16.22.3 Terumo Corporation Pipeline Products
16.22.3.1 Terumo Corporation Pipeline Products by Equipment Type
16.22.3.2 Terumo Corporation Pipeline Products by Development Stage
16.22.3.3 Terumo Corporation Pipeline Products by Therapy Area
16.22.3.4 Terumo Corporation Pipeline Products by Clinical Trials
16.22.3.5 Terumo Corporation Pipeline Products by News Summary
16.23 Biosense Webster, Inc.
16.23.1 Company Overview
16.24 CryoCath Technologies Inc.
16.24.1 Company Overview
16.24.2 CryoCath Technologies Inc. Pipeline Products
16.24.2.1 CryoCath Technologies Inc. Pipeline Products by Equipment Type
16.24.2.2 CryoCath Technologies Inc. Pipeline Products by Development Stage
16.24.2.3 CryoCath Technologies Inc. Pipeline Products by Therapy Area
16.24.2.4 CryoCath Technologies Inc. Pipeline Products by Clinical Trials
16.24.2.5 CryoCath Technologies Inc. Pipeline Products by News Summary
16.25 Siemens Healthcare
16.25.1 Company Overview
16.25.2 Value Chain Analysis
16.25.2.1 Manufacturing
16.25.2.2 Product Development
16.25.2.3 Sales and Marketing
16.26 C.R. Bard, Inc.
16.26.1 Company Overview
16.26.2 Value Chain Analysis
16.26.2.1 Manufacturing
16.26.2.2 Product Development
16.26.2.3 Sales and Marketing
16.26.3 C.R. Bard, Inc. Pipeline Products
16.26.3.1 C.R. Bard, Inc. Pipeline Products by Equipment Type
16.26.3.2 C.R. Bard, Inc. Pipeline Products by Development Stage
16.26.3.3 C.R. Bard, Inc. Pipeline Products by Therapy Area
16.26.3.4 C.R. Bard, Inc. Pipeline Products by Clinical Trials
16.27 Invatec S.r.l.
16.27.1 Company Overview
16.27.2 Invatec S.r.l. Pipeline Products
16.27.2.1 Invatec S.r.l. Pipeline Products by Equipment Type
16.27.2.2 Invatec S.r.l. Pipeline Products by Development Stage
16.27.2.3 Invatec S.r.l. Pipeline Products by Therapy Area
16.27.2.4 Invatec S.r.l. Pipeline Products by Clinical Trials
16.27.2.5 Invatec S.r.l. Pipeline Products by News Summary
16.28 ev3 Inc.
16.28.1 Company Overview
16.28.2 Value Chain Analysis
16.28.2.1 Manufacturing
16.28.2.2 Product Development
16.28.2.3 Sales and Marketing
16.28.3 ev3 Inc. Pipeline Products
16.28.3.1 ev3 Inc. Pipeline Products by Equipment Type
16.28.3.2 ev3 Inc. Pipeline Products by Development Stage
16.28.3.3 ev3 Inc. Pipeline Products by Therapy Area
16.28.3.4 ev3 Inc. Pipeline Products by Clinical Trials
16.28.3.5 ev3 Inc. Pipeline Products by News Summary
16.29 Cardiac Impulse S.r.l.
16.29.1 Company Overview
16.30 Gallini Medical s.r.I.
16.30.1 Company Overview
16.31 C.E.M. srl Electromedical Center Marche
16.31.1 Company Overview
16.32 Sorin Group Italia S.r.l
16.32.1 Company Overview
17 Recent Developments
17.1 Corporate Communications
17.1.1 Mar 19, 2009: Sorin Announces Board Changes
17.1.2 Jan 08, 2009: Sorin Announces Board And Management Changes
17.1.3 Nov 25, 2008: Sorin Announces Board Resignations
17.2 Product News
17.2.1 Apr 06, 2009: Evalve, Inc. Announces First Patient Enrollment In The Access-Europe Study
17.2.2 Jan 14, 2009: IN.PACT, First Drug-Eluting Balloon To Treat Atherosclerosis Below The Knee Launched By Invatec
17.2.3 Dec 31, 2008: INVATEC's New Mo.Ma Ultra Introduced At ICCA 08, Frankfurt
17.2.4 Oct 21, 2008: First Patients Treated In Italy With The Percutaneous Mitraclip System
18 Appendix
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panel Validation
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: Number of Doctors by Specialty in Spain, 2003-2007
Table 2: Number of Hospital Wards by Specialty in Spain, 2003-2007
Table 3: Healthcare Institutions in Spain, 2007
Table 4: Hospital Beds by Type in Spain, 2007
Table 5: Number of Healthcare Personnel in Spain, 2007
Table 6: Number of Selected Medical Equipment in Spain, 2007
Table 7: Cardiovascular Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Table 8: Cardiovascular Devices, Spain, Overall Revenue ($ mn), 2000-2015
Table 9: Cardiovascular Devices, Spain, Cross-Category Analysis, 2000-2015
Table 10: Cardiovascular Devices, Spain, Overall Revenue ($ mn), Historic, 2000-2008
Table 11: Cardiovascular Devices, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
Table 12: Cardiovascular Devices, Spain, Category Volume (Units), 2000-2015
Table 13: Cardiovascular Devices, Spain, Category Volume (Units), Historic, 2000-2008
Table 14: Cardiovascular Devices, Spain, Category Volume (Units), Forecast, 2008-2015
Table 15: Cardiovascular Devices, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 16: Cardiac Rhythm Management, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 17: Cardiac Rhythm Management, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 18: Cardiac Resynchronisation Therapy, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 19: Cardiac Resynchronisation Therapy, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 20: Implantable Cardioverter Defibrillator, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 21: Implantable Cardioverter Defibrillator, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 22: Pacemaker, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 23: Pacemaker, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 24: Cardiac Rhythm Management, Spain, Volume (Units) by Segment, Historic, 2000-2008
Table 25: Cardiac Rhythm Management, Spain, Volume (Units) by Segment, Forecast, 2008-2015
Table 26: Cardiac Resynchronisation Therapy, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 27: Cardiac Resynchronisation Therapy, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 28: Implantable Cardioverter Defibrillator, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 29: Implantable Cardioverter Defibrillator, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 30: Pacemaker, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 31: Pacemaker, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 32: Cardiac Rhythm Management, Spain, Average Price ($), Historic, 2000-2008
Table 33: Cardiac Rhythm Management, Spain, Average Price ($), Forecast,, 2008-2015
Table 34: Cardiac Rhythm Management, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 35: Cardiac Rhythm Management, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Spain, Volume (Units) by Segment, Historic, 2000-2008
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Spain, Volume (Units) by Segment, Forecast, 2008-2015
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Spain, Average Price ($), Historic, 2000-2008
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Spain, Average Price ($), Forecast,, 2008-2015
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 44: Cardiovascular Prosthetic Devices, Spain, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 45: Cardiovascular Prosthetic Devices, Spain, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 46: Cardiac Assist Devices, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 47: Cardiac Assist Devices, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 48: Prosthetic Heart Valve, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 49: Prosthetic Heart Valve, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 50: Cardiovascular Prosthetic Devices, Spain, Volume (Units) by Segment, Historic, 2000-2008
Table 51: Cardiovascular Prosthetic Devices, Spain, Volume (Units) by Segment, Forecast, 2008-2015
Table 52: Cardiac Assist Devices, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 53: Cardiac Assist Devices, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 54: Prosthetic Heart Valve, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 55: Prosthetic Heart Valve, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 56
Order Form
       * Please reference product number R3480-13927 when ordering or inquiring.
PUBLICATION:   Spain Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
QTY. FORMAT PRICE TOTAL
  Online Download$2,500.00   
  Global Site License$7,500.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com